Literature DB >> 23277647

Application of carvedilol in a dog with pseudoephedrine toxicosis-induced tachycardia.

Min-Hee Kang1, Hee-Myung Park.   

Abstract

A 15-year-old Yorkshire terrier dog was presented after ingesting 1 capsule of an over-the-counter cold medication containing pseudoephedrine (120 mg/capsule) and cetirizine (5 mg/capsule). Treatment was initiated with acepromazine and carvedilol. The dog responded well to treatment. This is the first known case report using carvedilol to control pseudoephedrine toxicosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23277647      PMCID: PMC3377463     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  15 in total

1.  Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.

Authors:  Gerald Beddies; Philip R Fox; Mark D Papich; Venkata-Rangaro Kanikanti; Ralph Krebber; Bruce W Keene
Journal:  Am J Vet Res       Date:  2008-12       Impact factor: 1.156

2.  Tachycardia induced cardiomyopathy in dogs; relation between chronic supraventricular and chronic ventricular tachycardia.

Authors:  I Zupan; P Rakovec; N Budihna; A Brecelj; M Kozelj
Journal:  Int J Cardiol       Date:  1996-09       Impact factor: 4.164

3.  Suspected caffeine and ephedrine toxicosis resulting from ingestion of an herbal supplement containing guarana and ma huang in dogs: 47 cases (1997-1999).

Authors:  T G Ooms; S A Khan; C Means
Journal:  J Am Vet Med Assoc       Date:  2001-01-15       Impact factor: 1.936

4.  Dextromethorphan- and pseudoephedrine-induced agitated psychosis and ataxia: case report.

Authors:  R J Roberge; K H Hirani; P L Rowland; R Berkeley; E P Krenzelok
Journal:  J Emerg Med       Date:  1999 Mar-Apr       Impact factor: 1.484

5.  Tachycardia-induced cardiomyopathy in a young Boxer dog with supraventricular tachycardia due to an accessory pathway.

Authors:  S F Foster; G B Hunt; S P Thomas; D L Ross; M R B Pearson; R Malik
Journal:  Aust Vet J       Date:  2006-09       Impact factor: 1.281

6.  Unexpected infant deaths associated with use of cough and cold medications.

Authors:  Mary E Rimsza; Susan Newberry
Journal:  Pediatrics       Date:  2008-08       Impact factor: 7.124

7.  Cardiovascular and renal effects of carvedilol in dogs with heart failure.

Authors:  Masami Uechi; Takahiro Sasaki; Kouichiro Ueno; Taiji Yamamoto; Yumi Ishikawa
Journal:  J Vet Med Sci       Date:  2002-06       Impact factor: 1.267

8.  Metabolism of carvedilol in dogs, rats, and mice.

Authors:  W H Schaefer; J Politowski; B Hwang; F Dixon; A Goalwin; L Gutzait; K Anderson; C DeBrosse; M Bean; G R Rhodes
Journal:  Drug Metab Dispos       Date:  1998-10       Impact factor: 3.922

9.  Carvedilol in dogs with dilated cardiomyopathy.

Authors:  Mark A Oyama; D David Sisson; Robert Prosek; Barret J Bulmer; Mike W Luethy; Virginia Luis Fuentes
Journal:  J Vet Intern Med       Date:  2007 Nov-Dec       Impact factor: 3.333

10.  Toxicity of over-the-counter stimulants.

Authors:  P Pentel
Journal:  JAMA       Date:  1984-10-12       Impact factor: 56.272

View more
  1 in total

1.  ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats.

Authors:  Mark J Acierno; Scott Brown; Amanda E Coleman; Rosanne E Jepson; Mark Papich; Rebecca L Stepien; Harriet M Syme
Journal:  J Vet Intern Med       Date:  2018-10-24       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.